The global market for Compression Therapy is projected to reach US$3.3 billion by 2025, driven by the rising incidence of venous ulcers supported by aging population and the obesity epidemic. Weak blood circulation in the limbs and malfunctioning venous valves due to leg injury/surgery; obesity; prolonged periods without movement and blood clots in veins, are chief causes of venous ulcers. If left untreated, chronic venous disorders can result in the development of dilated veins also known as “spider veins.” Compression therapy represents the first line of treatment for venous ulcers and is aimed at increasing blood flow to lower limbs and extremities by simple application of gentle pressure. Few of the benefits of this therapy include muscle compression to mobilize blood flow and fight inflammation and edema; reduced muscle soreness; helps loosen up the veins; relives pain by reducing lactic acid build-up in muscles; restores valve competence; reduces venous reflux (VR); acce...